reported that knockout of guanylate-binding protein 5 suppressed NLRP3 inflammasome activation and secretion of IL-1β and IL-18, leading to decreased proteinuria, blood urea nitrogen, and creatinine levels, improved renal pathology, and slowed LN progression [151]. The gene discussed is NLRP3; the disease is lobular neoplasia.